Yong Beom Kim
Overview
Explore the profile of Yong Beom Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
161
Citations
984
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kim N, Suh D, Kim K, No J, Kim Y, Kim M, et al.
PLoS One
. 2024 Jun;
19(6):e0304704.
PMID: 38833451
Objective: To evaluate the diagnostic performance of circulating tumor cells (CTCs) using tapered-slit membrane filter (TSF)-based chipsets for the differential diagnosis of adnexal tumors. Methods: A total of 230 women...
12.
Han K, Jeong Y, Suh Y, Suh D, Kim K, Kim Y, et al.
PLoS One
. 2024 Mar;
19(3):e0297495.
PMID: 38551922
Vitamin D deficiency is a worldwide health issue especially in women. Serum vitamin D concentrations vary depending on the weather. However, the ideal vitamin D supplementation strategy related to weather...
13.
Lee H, Lee B, Choi H, Lee M, Lee K, Lee T, et al.
Cancers (Basel)
. 2024 Feb;
16(4).
PMID: 38398200
This study examined the impact of hormone replacement therapy (HRT) on the occurrence of various cancers in postmenopausal women with de novo or a history of endometriosis. In the datasets...
14.
Yoo J, Lee S, Nam E, No J, Park J, Song J, et al.
J Gynecol Oncol
. 2024 Feb;
35(2):e44.
PMID: 38389404
This fifth revised version of the Korean Society of Gynecologic Oncology practice guidelines for the management of cervical cancer incorporates recent research findings and changes in treatment strategies based on...
15.
Yoon H, Suh D, Kim K, No J, Kim Y, Kim H
Gynecol Oncol
. 2024 Feb;
184:132-138.
PMID: 38309030
Objective: We investigate the prognostic role of β-catenin and L1 neuronal cell-adhesion molecule (L1CAM) according to risk groups in endometrial carcinomas (EC). Methods: A total of 335 EC patients were...
16.
Kim J, Kim D, Kim J, Noh J, Hwang W, Baek M, et al.
J Gynecol Oncol
. 2024 Jan;
35(2):e45.
PMID: 38216137
The Korean Society of Gynecologic Oncology (KSGO) had been making an effort to standardize and enhance the quality of domestic uterine corpus cancer treatment by developing updated clinical practice guidelines...
17.
Lee B, Chang S, Kwon B, Son J, Lim M, Kim Y, et al.
J Gynecol Oncol
. 2024 Jan;
35(1):e43.
PMID: 38178704
Since the latest practice guidelines for ovarian cancer were developed by the Korean Society of Gynecologic Oncology (KSGO) in 2021, many studies have examined the efficacy and safety of various...
18.
Lee B, Chang S, Kwon B, Son J, Lim M, Kim Y, et al.
PLoS One
. 2023 Nov;
18(11):e0294647.
PMID: 37976295
Objectives: This meta-analysis was undertaken to systematically evaluate the effects of poly (ADP-ribose) polymerase inhibitor (PARPi) maintenance therapy on the survival of newly diagnosed advanced epithelial ovarian cancer (EOC) patients....
19.
Kim Y, Aiob A, Kim H, Suh D, Kim K, Kim Y, et al.
Biomedicines
. 2023 Oct;
11(10).
PMID: 37893065
This study investigated PD-L1 expression in endometrial cancer, its links with prognostic factors, and survival outcomes in 232 patients. Of these, 73 (31.5%) had PD-L1-positive tumors and 159 (68.5%) had...
20.
Aiob A, Kim Y, Kim K, Kim H, Kim Y, Kim D, et al.
Obstet Gynecol Sci
. 2023 Oct;
66(6):537-544.
PMID: 37839795
Objective: To examine the efficacy of MSH6 and PMS2 immunohistochemistry (IHC) as a screening method for Lynch syndrome in endometrial cancer patients. Methods: Through multidisciplinary discussions, an institutional MSH6 and...